The M-band represents a transverse structure in the center of the sarcomeric A-band and provides an anchor for the myosin-containing thick filaments. In contrast to other sarcomeric structures, eg, the Z-disc, only few M-band-specific proteins have been identified to date, and its exact molecular composition remains unclear.
T he sarcomeres of cardiac and skeletal muscle represent the basic molecular unit for contractile force generation and transmission. 1 The thin filaments of the sarcomere consist of actin fibers that are crosslinked at the Z-disc, whereas the thick filaments, mainly composed of myosin molecules, are attached to the M-band, which provides lateral stabilization. 2 Beyond a mere mechanical function, these crucial subsarcomeric structures and their molecular components have been implicated in the regulation of the dynamics of muscle contraction and the sensing of cardiomyocyte stress. 3, 4 Moreover, the sarcomeric Z-disc, as well as the M-band, has increasingly been recognized as a hub for signaling pathways that mediate diverse intracellular processes including cell growth and differentiation, as well as protein turnover and gene expression. 2,4 -6 At the level of the sarcomeric Z-disc, the conversion of structural and mechanical demands to gene transcription is mediated by several specific pathways, including calcium-dependent signaling via the calcineurin-NFATc pathway, 7-9 extracellular signal-regulated kinase 2, 10 protein kinase C, 11 and the ubiquitin modification machinery (eg, via MURF-ligases). 12, 13 More recently, the sarcomeric M-band has also been shown to play a critical role in mechanotransduction. Gautel and colleagues were able to show that an M-band signaling complex, consisting of titin, Nbr1, p62, and MURF2 mediates gene expression and muscle protein turnover in response to biomechanical stress via nuclear translocation of the transcription factor SRF. 14 The physiological and pathophysiological importance of Z-disc and M-band proteins is further underscored by the fact that both subsarcomeric structures represent hot spots for inherited human cardiomyopathy and/or muscular dystrophy. 15, 16 Although several components of the M-band have already been identified years ago, including specific titin domains, 17 the myomesin-1, -2, and -3, 18 -20 and obscurin, 5 its exact molecular composition is still not completely resolved. Moreover, the small number of known M-band proteins suggests that additional components are yet to be discovered.
Thus, in an effort to identify novel sarcomeric proteins, we searched expressed sequence tag (EST) databases for previously uncharacterized genes with high abundance in cardiac and muscle cDNA libraries. Using this bioinformatic approach, we found an open reading frame encoding for a 335-aa protein "LRRC39," which we termed myomasp (Myosin-interacting, M-band-associated stress-responsive protein). Here, we show that myomasp/LRRC39 is a highly cardiac-enriched protein that localizes to the sarcomeric M-band and directly binds to the C-terminal tail domain of myosin heavy chain (MYH)7. Knockdown of myomasp/ LRRC39 expression in cardiomyocytes results in the inhibition of SRF-dependent signaling and significant downregulation of MYH7 mRNA other M-band proteins such as myomesin-1 and -2. Conversely, the expression of stressresponsive genes such as GDF-15 and brain natriuretic peptide (BNP) is markedly induced on myomasp ablation. Finally, in vivo knockdown of myomasp/LRRC39 in zebrafish resulted in reduced contractility, cardiomyopathy, and disturbed ultrastructural M-band architecture, consistent with the notion that this novel M-band component plays an essential role in cardiac function and integrity.
Methods
Detailed descriptions of the experimental procedures for cloning and the subsequent bioinformatics, Northern blot analysis, Western blot analyses, immunofluorescence, yeast 2-hybrid assays, tissue culture, immunoprecipitations, and reporter gene assays, as well as zebrafish injection procedures, fractional shortening measurement, generation of engineered heart tissues, video optical analysis, microarray hybridizations, and transverse aortic constriction are provided in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
Statistical analyses of the data were carried out using ANOVA followed by Student-Newman-Keuls post hoc tests. If appropriate, Student's t test was used (2-sided, assuming similar variances). Probability values of Ͻ0.05 were considered statistically significant.
Results

Myomasp/LRRC39 Is an Evolutionarily Conserved Cardiac Protein
In an effort to identify previously unknown cardiac-and muscle-enriched genes, we searched the EST databases for uncharacterized sequences predominantly found in cardiac cDNA libraries. 21 The data extraction mainly relied on the T-STAG (Tissue-Specific Transcripts and Genes; http://tstag. molgen.mpg.de) and the Unigene (National Center for Biotechnology; http://www.ncbi.nlm.nih.gov/unigene) databases. Several of the identified ESTs corresponded to the human Unigene cluster Hs.44277 or the Rattus norvegicus Unigene cluster Rn.79735. ESTs in these clusters were significantly enriched for heart and muscle compared with all other tissues. The resulting NCBI Reference Sequences (NM_144620. 2 [human] or NM_001109637.1 [rat]) were used as templates for the design of primers for the amplification of the complete open reading frames, which encode for a novel 335-aa (human)/334-aa (rat) leucine-rich protein with a calculated molecular mass of 38.8 kDa (human)/38.7 kDa (rat), respectively. Interestingly, 6 leucine-rich repeat motifs (LRR/ LRR_TYPE) were identified in the protein sequence, placing myomasp into the LRR_RI superfamily ( Figure 1A) . A protein sequence alignment between the putative human, mouse, rat, and zebrafish protein homologs revealed high evolutionary sequence conservation among species ( Figure  1B ). Molecular cloning of human (NM_144620.2), murine (NM_027321.3), and rat (NM_001109637.1) myomasp complete open reading frames confirmed the predicted amino acid sequences. Of note, myomasp is identical to a largely uncharacterized protein termed LRRC39, identified by Uchida et al in a screen for cardiac-enriched genes with unknown function. 22 
Myomasp/LRRC39 Is Predominantly Expressed in Heart and Skeletal Muscle
To confirm the predicted expression pattern of myomasp/ LRRC39 (Figure 2A , left) in different human tissues, we performed quantitative real-time PCR experiments using cDNAs from multiple human tissues and myomasp/LRRC39-specific probes and primers (Figure 2A, right) . Similar to the calculated pattern, a strong expression in heart and skeletal muscle was observed, whereas other tissues revealed no significant signal. Consistently, hybridization of myomasp/ LRRC39-specific cDNA probes with human or mouse multiple tissue Northern blots confirmed heart-and skeletal muscle-specific gene expression of both human and murine myomasp/LRRC39 ( Figure 2B ). Compared to quantitative real-time PCR (Figure 2A ), the Northern blot analyses revealed a higher myomasp/LRRC39 expression in the heart than skeletal muscle tissue in mice ( Figure 2B ). To also analyze the expression of myomasp/LRRC39 on the protein level, a Western blot of several rat tissues extracts was probed with a polyclonal antibody against myomasp/ LRRC39. Myomasp/LRRC39-and control-transfected HEK-293T cells served as positive and negative controls, respectively. Again, these experiments revealed a strong expression of myomasp/LRRC39 protein in rat heart and skeletal muscle tissue at the predicted size of Ϸ39 kDa ( Figure 2C ). In addition to the expression pattern on RNA level, Western blot experiments also revealed a distinct protein expression in the kidneys.
Myomasp/LRRC39 Interacts With Myosin Heavy Chains
To identify potential protein interaction partners for myomasp/LRRC39, we performed yeast 2-hybrid experiments and screened human heart-and skeletal muscle-derived cDNA libraries. Among several potentially myomaspinteracting proteins, we found multiple clones encoding for the C termini of different myosin heavy chain genes (MYH1, MYH2, MYH6, MYH7) ( Figure 3A) . To confirm the interaction between MYH7 and myomasp/LRRC39, we conducted coimmunoprecipitation experiments in eukaryotic HEK-293T cells. These cells were transiently cotransfected with HA-tagged full-length myomasp/LRRC39, together with Myc-tagged full-length MYH7 or the respective empty vector controls. Results revealed an intense coprecipitation of myomasp with MHY7, whereas no specific band was observed with empty vector alone ( Figure 3B ). an A-band localized head and neck region, responsible for actin-myosin interaction, and a C-terminal tail region crosslinked at the sarcomeric M-band. 23 These mapping studies revealed that myomasp/LRRC39 interacts with the C-terminal 282 amino acids of MYH7, consistent with the notion that myomasp/LRRC39 could be involved in regulating and/or anchoring myosin heavy chain molecules at the sarcomeric M-band ( Figure 3C ).
Myomasp/LRRC39 Is a Novel Component of the Sarcomeric M-Band
Given the high expression levels of myomasp/LRRC39 in the myocardium and the protein-protein interaction with MYH7, we next aimed to determine its subcellular localization in isolated adult rat cardiomyocytes. A strong signal was detected at the sarcomeric M-band, as shown by coimmunostaining with a well-characterized N2A M-band-specific titin antibody ( Figure 4A ). 24 Consistently, simultaneous staining of myomasp/LRRC39 with the Z-disc-specific calsarcin-1 antibody 25 revealed no overlapping fluorescence pattern, excluding a sarcomeric Z-disc localization for myomasp/ LRRC39 ( Figure 4A ). Likewise, A-band staining was investigated with a MYBPC3 antibody, because MYBPC3 has been shown to bind to the myosin subfragment-2 (S2) neck region with its C terminus 26 and to localize to the sarcomeric A-band. 27 Simultaneous staining of MYBPC3 and myomasp/ LRRC39 excluded an A-band localization of myomasp/ LRRC39 ( Figure 4A ). In line with the subcellular localization in ARVCM, cryosections of intact rat heart and skeletal muscle tissues again revealed a sarcomeric M-band signal for myomasp ( Figure 4B ) and colocalization with the M-bandspecific titin N2A domain ( Figure 4B ). Taken together, these data reveal that myomasp/LRRC39 is a novel component of the sarcomeric M-band.
Myomasp/LRRC39 Knockdown Reveals Differential Regulation of Sarcomeric and Stretch-Responsive Genes
The sarcomeric M-band has previously shown to be a hub for signaling molecules involved in cardiomyocyte gene regulation. 14 To test whether myomasp/LRRC39 participates in the regulation of gene expression as well, we devised a knockdown experiment in neonatal rat cardiomyocytes, using an adenovirally encoded synthetic microRNA (miMyomasp). Knockdown efficiency was Ͼ85% compared with an appropriate control virus expressing scrambled microRNAs (miNeg) (Online Figure II) . Seventy-two hours after viral infection total RNA was isolated, and after quality control, amplification, and labeling, the cRNA was subsequently hybridized on Illumina Rat Sentrix-12 BeadChips. For comparison of the expression profile of myomasp/LRRC39 knockdown cardiomyocytes and control cells, the acquired data were processed and analyzed with Illumina Bead studio software. The distribution of the normalized differentially expressed genes (Ͼ4-fold) of 3 miMyomasp knockdown samples compared with 3 miNEG controls is shown in Online Figure I , A. Only those genes with a probability value of Ͻ0.005, which were up-or downregulated Ͼ4-fold and showing an array SD of Ͼ5-fold and a bead SD of Ͼ4-fold were taken into account for further analysis. By applying these selection criteria, 367 genes were found to be differentially expressed. A total of 129 genes were found to be upregulated after miMyomasp knockdown, whereas 238
showed a significant downregulation. The normalized data of the 367 genes that fulfilled the selection criteria are displayed in a heat map for each sample (Online Figure I, A) . Hierarchical clustering between the sample groups revealed highly reproducible results and low variance (Online Figure I, B) . Because myomasp/LRRC39 localizes to the M-band and interacts with MYH7, we focused our interest on the regulation of M-band-associated proteins. Of note, the microarray analyses of myomasp/LRRC39-deficient cardiomyocytes showed a highly significant reduction of MYH7B (Ϫ25.6-fold), as well as the M-band proteins myomesin 1 (Ϫ4.5-fold) and myomesin 2 (Ϫ18.8-fold) compared with NRVCMs infected with miNeg (Online Figure I, C) . The downregulation of myomesin 1 and myomesin 2 was subsequently confirmed by quantitative real-time PCR experiments ( Figure  5A ). Knockdown of myomasp/LRRC39 led to a significant 38.4% reduction of myomesin 1 (PϽ0.01) and 44.7% reduction of myomesin 2 expression, respectively (PϽ0.01). Likewise, MYH7B mRNA was found to be a significantly downregulated (Ϫ37%, PϽ0.05; Figure 5B ). In contrast, the stretch-sensitive marker gene BNP revealed a marked upregulation of (6.3-fold increase, PϽ0.001; Figure 5B ). Remarkably, one of the genes that displayed the most dramatic differential regulation (23.7-fold induction; Online Figure I, C) was the stress-and stretch-sensitive marker GDF15. 28, 29 The significant upregulation of GDF15 could be confirmed by quantitative real-time PCR and Western blot experiments (5.7-fold, PϽ0.01; Figure 5C ). Because both GDF-15 and BNP are highly sensitive to mechanical stress, 28 -30 we asked whether myomasp/LRRC39 expression itself is also regulated in an in vitro model for stretch of cardiomyocytes ( Figure  6A ). Interestingly, static biaxial stretch of NRVCM for 24 hours led to a significant reduction in myomasp/LRRC39 mRNA expression (Ϫ78%, PϽ0.001). To further substantiate this finding, we analyzed C57BL6 mice which underwent transverse aortic constriction for 4 weeks (nϭ11) and compared them to sham-operated littermates (nϭ12; Figure 6B ). Consistently, transverse aortic constriction in mice led also to a highly significant cardiac downregulation of myomasp/ LRRC39 mRNA, as assessed by quantitative real-time PCR analysis (PϽ0.001). Thus, downregulation of myomasp leads to suppression of the expression of other M-band-associated proteins including myomesin1 (MYOM1) and myomesin 2 (MYOM2). Conversely, myomasp deficiency results in the induction of the stretch-responsive genes BNP and GDF15. The marked downregulation of endogenous myomasp mRNA expression on biomechanical stress implies a role for myomasp/LRRC39 in the stretch signaling cascade.
Downregulation of Myomasp/LRRC39 Inhibits SRF-Dependent Signaling
It has previously been suggested that sarcomeric M-band proteins participate in the cardiomyocyte response to biomechanical stress via modulation of SRF-dependent signaling pathways. 14 Thus, we tested the hypothesis that myomasp/ LRRC39 might also participate in SRF-dependent transcriptional regulation. By measuring luciferase activity of NRVCMs coinfected with a reporter adenovirus (Ad) expressing luciferase under control of the SRF-responsive sm22 promotor ( Figure 6C ), we could show a significant and dose-dependent reduction of SRF activity on microRNAmediated myomasp knockdown (Ϫ37.8% at 90 infectious units [ifu]; PϽ0.001; Figure 6D and 6E). Taken together, these data imply that myomasp/LRRC39 is involved in the regulation of M-band proteins via modulation of SRFdependent gene expression.
Functional Consequences of Myomasp/LRRC39 Knockdown In Vitro
To elucidate the functional consequences of myomasp/ LRRC39 downregulation on cardiomyocyte contraction and force generation, we used fibrin-based mini-engineered heart tissues (FBMEs) prepared as described in detail in the Online Methods section ( Figure 7A ). After 6 days of culture, FBMEs where infected with 50-ifu AdmiMyomasp or 50-ifu control virus (AdmiNeg). After development of a spontaneous and synchronous beating pattern (8 to 10 days), force generation and fractional shortening of FBMEs were measured by video optical recordings on days 18 to 20. Infection efficiency and viral penetration of engineered heart tissue constructs was visually controlled by green fluorescent protein (GFP) expression ( Figure 7B ). FBMEs infected with 50-ifu AdmiMyomasp showed a significant reduction in force generation (70 versus 120 mN, PϽ0.002, at a calcium concentration of 0.5 mmol/L; 100 mN versus 160 mN, PϽ0.05, at 1.5 mmol/L calcium) and markedly impaired fractional shortening (4% versus 7%, PϽ0.005, at 0.5 mmol/L calcium; 6% versus 8%, PϽ0.05, at 1.5 mmol/L calcium content) compared with FBMEs infected with control virus (Figure 7C and 7D) . Representative measurements and corresponding FBMEs are shown in Figure 7E (AdmiNeg) and Figure 7F (AdmiMyomasp), respectively.
Functional Consequences of a Myomasp/LRRC39 Knockdown In Vivo
To further elucidate myomasp/LRRC39 function in vivo, we injected zebrafish embryos with morpholino (MO)-modified antisense oligonucleotides directed against the splice donor site of intron 2 of zebrafish myomasp/LRRC39. When injected with 4 ng of MO-Myomasp, 76.9% of injected embryos (nϭ267) ( Figure 8A ) revealed severe contractile dysfunction ( Figure 8B ; Online Movie 1), whereas heart function of embryos injected with a standard control MO was completely unaltered ( Figure 8B ; Online Movie 2). In myomasp morphants, ventricular and atrial fractional shortening significantly decreased to 6% and 11.6%, respectively (Figure 8C and 8D) . Hence, to evaluate whether myomasp deficiency interferes with key steps of zebrafish heart development and thereby leads to the observed heart failure phenotype, we examined expression of cardiac chamberspecific proteins and mRNAs by immunostainings and antisense RNA in situ hybridization, respectively, as well as cardiac structure of myomasp morphants by histology. We found that loss of myomasp function does not interfere with crucial steps of cardiogenesis, such as heart tube looping, chamber demarcation, and the differentiation of ventricular and atrial cardiomyocytes ( Figure 8E ). Additionally, expression of cardiac genes such as the cardiac myosin light chain (cmlc2) and chamber-specific myosin heavy chains (vmhc, amhc, MF20, S46) were found to be expressed in the correct heart chamber-restricted pattern and in normal amounts, demonstrating that myomasp deficiency does not lead to the misexpression of these contractile proteins or severe alteration in cardiogenesis, as observed in several other heart failure zebrafish mutants. [31] [32] [33] To further assess whether impaired cardiomyocytes cytoarchitecture accounts for the contractile dysfunction of myomasp-deficient zebrafish embryos, we analyzed the ultrastructure of cardiac muscle cells by transmission electron microscopy. At 72 hours postfertilization, myomasp-deficient morphants show no clear ultrastructural defects in cardiac sarcomeres; however, no mature M-Band was definable neither in myomasp-deficient morphants nor in control MOinjected zebrafish. In contrast, deficiency of myomasp/ LRRC39 leads to a marked narrowing of the skeletal muscle M-band accompanied "bare zone." This A-band/M-band transition also appears "fuzzier" as compared with control MO-injected zebrafish. Other sarcomeric structures of myomasp-deficient morphants appeared completely unaltered. Arrays of thin myofilaments, as well as Z-discs, were found to be regular. Furthermore, the content and morphology of other cardiomyocytes components such as mitochondria and cell nuclei also appeared unaffected by the loss of myomasp function ( Figure 8F ).
Discussion
Here, we provide the detailed molecular characterization of a highly cardiac-and skeletal muscle-enriched protein, termed myomasp/LRRC39. Myomasp is a novel component of the sarcomeric M-band and is involved in SRF-dependent transcription and stress-responsive signaling. Moreover, myo- masp/LRRC39 is required for proper cardiac function both in vitro and in vivo.
Myomasp/LRRC39, a Leucine-Rich Repeat Protein
Myomasp/LRRC39 contains a coiled-coil domain and 6 leucine-rich repeat domains and is highly conserved among species. Although we could not detect any closely related proteins in the database, leucine-rich repeat motifs are found in an increasing number of newly discovered proteins with diverse cellular functions, including cell adhesion, signal transduction, and regulation of gene expression. 34 The primary function of the leucine-rich repeat domain is believed to provide a structural framework for protein-protein interactions. 34 In 2007, Kim et al were the first to give insight into the importance of a muscle-specific, leucine-rich-containing protein, LRRC10. 35 Using zebrafish as an in vivo model, they demonstrated that LRRC10-defective morphants showed severe morphological and functional defects, including heart looping failure and decreased ejection fraction and cardiac output, as well as early embryonic lethality. Yet, the underlying mechanisms and potential signaling pathways regulated by LRRC10 still remain unclear.
Myomasp/LRRC39 Is a Novel Sarcomeric M-Band Protein
In contrast to LRRC10, which is localized to T-tubuli and the Z-disc, 35, 36 myomasp/LRRC39 is exclusively detected at the sarcomeric M-band. Traditionally, the M-band has been viewed as a transverse structure providing mechanical an- . Ventricular and atrial FS of myomasp morphants markedly decreases over time. E, At 48 hours postfertilization, the expression of cardiac myosin proteins (MF20/S46), as well as mRNA expression of cardiac myosin light chain 2 (cmlc2), atrial myosin heavy chain (amhc), and ventricular myosin heavy chain (vmhc), is unaffected by the loss of myomasp function, as revealed by whole-mount immunostaining and antisense RNA in situ hybridization. Endocardial and myocardial cell layers are also unaltered in myomasp morphant zebrafish embryos, indicating no severe changes in cardiogenesis. In summary, histological analysis of zebrafish MO-myomasp knockdown showed no obvious alterations of cardiac structures. A indicates atrium; en, endocardium; my, myocardium; V, ventricle. F, Ultrastructural analysis of heart and skeletal muscle tissues in myomasp morphant zebrafish embryos. Left, No clear ultrastructural defect in cardiac sarcomeres of myomasp-deficient morphants; however, no mature M-Band architecture was definable neither in knockout nor in control zebrafish. In high-resolution and high-magnification EM images, knockdown of myomasp/LRRC39 leads to sarcomere defects with narrowing of the skeletal muscle M-band/A-band transition ("bare-zone," indicated by white arrows). The M-Band to A-Band transition also appears fuzzier.
choring and alignment of the thick filaments of the sarcomere. Data from several studies indicate that regular M-band assembly is needed for proper packing of the thick filaments with appropriate distances to the thin filaments at the onset of contraction (termed "M-bridges"). 37, 38 A critical component in this model is the giant protein titin, which extends from the thin filaments at the Z-discs to the thick filaments at the M-band, thus providing mechanical cross-stabilization and adjustment of force imbalances between the filaments. 39 Interestingly, the assembly and morphology of M-bands is variable in different muscle fibers. 5 Fast muscle types have a 3-line M-band pattern; M1, -2, -4; whereas slow muscle cells show a 4-line pattern; M1, -2, -4, -6. In addition to titin, 2 other components of the M-band are thought to function as M-bridges, myomesin 1 and myomesin 2. Both proteins are aligned in antiparallel dimers to the central zone of myosins (M1 line) and to the C-terminal region of titin (M4 line). The nature of the M-line-bordering bare zone and the M6Ј/M6 lines are not known at present. 40 Differential expression levels of mature myomesin and an alternatively spliced embryonic ("EH")-myomesin isoform (initially described as skelemin) are thought to contribute to specific functional and structural features of different muscle types and developmental stages. 19, 41, 42 For example, a decreased amount of myomesin 2 in slow muscle fibers results in an increase of titin compliance 43 and "fuzzy" sarcomeres. In contrast, fast muscle fibers display the highest content of mature myomesin and the lowest EH-myomesin level associated with a high order of M-band organization. Fast-type fibers therefore are thought to have the highest force generation capacity, whereas fuzzy, embryonic sarcomeres reveal less contractile efficiency but instead gain passive mechanical stability. 43 In this context, we could show that knockdown of myomasp/ LRRC39 results in a significant reduction of myomesin 1 and -2 gene expression, which may explain the reduced force generation of myomasp-depleted engineered heart tissue and zebrafish hearts. Moreover, we could identify the C-terminal rod domain of MYH7 as an interacting partner for myomasp/ LRRC39, thus representing a direct link to an important M-band structure. Of note, it has been shown that myomesins bind to both myosin 44 and titin 45 at the sarcomeric M-band. One might speculate that the knockdown of myomasp/ LRRC39 may lead to a decrease in M-band crosslinking and stability and a reduced adaptive capacity to force imbalances or stretch, which may have led to an activation of stretchresponsive genes such as BNP and GDF-15.
A Role for Myomasp/LRRC39 in Biomechanical Stress Signaling?
Recently, a direct role for the M-band in intracellular signaling processes and mechanotransduction is emerging, 14 providing another potential link between impaired M-band composition and altered cardiomyocyte gene expression. In this context, we observed a significant downregulation of endogenous myomasp/LRRC39 in stretched cardiomyocytes, a well characterized model in which an upregulation of BNP and GDF15 has already been shown. 28 This finding was further corroborated by analyzing C57BL6 mice which underwent transverse aortic constriction. In this in vivo model we also observed a significant downregulation of endogenous myomasp/LRRC39 mRNA, further supporting the notion that myomasp is involved in biomechanical stress signaling. Moreover, not the only the structural composition of the M-band may play a role in stretch sensing but the M-band itself could serve as a nodal point in signaling. In agreement with this hypothesis, Gautel and colleagues 14 were able to show that mechanical stress leads to force-induced conformational changes in the kinase domain of titin. The activation of the kinase by stretch facilitates its interaction with Nbr1 and p62, followed by the binding of the ubiquitin ligase MURF-2. MURF-2 in turn interacts with the transcription factor SRF to inhibit its nuclear localization and thus its transcriptional activity. As a result the prohypertrophic response elicited by mechanical forces is attenuated. 14 Similarly, we observed a suppression of SRF activity in cardiomyocytes on administration of increasing doses of myomasp/ LRRC39 knockdown virus. The suppression of SRFdependent transcription by downregulation of myomasp/ LRRC39 might at least partly explain the reduced expression of myomesins and myosins as these genes are known to contain SRF-responsive CArG boxes in their promoter region. 46 Yet, it is likely that competing signaling pathways exist because, for example, cardiac actin was not differentially regulated (data not shown).
Moreover, proper and stoichiometric protein composition of the M-band during stretch is needed to ensure a quick reaction to changes in sarcomeric force and/or enhanced stiffness/reduced compliance. 5 Thus, an impaired M-band composition may induce stress-responsive pathways, independently of any direct effects on SRF signaling. Our data support a model where artificial myomasp knockdown in vitro partly mimics these effects of stretch, leading to the observed induction of immediate responsive genes like BNP and GDF-15.
Finally, the fact that myomasp-null zebrafish morphants show ultrastructural M-band alterations with a marked reduction of the A-band/M-band transition zone (bare zone) supports the concept that subtle structural perturbations may contribute to the observed functional defects. Regardless of the precise mechanism, our data underline the importance of proper M-band composition in general, and myomasp/LRRC39 expression in particular, in proper cardiomyocyte function.
Myomasp/LRRC39 As a Candidate Gene for Cardiomyopathy
Another important aspect with possible regulatory function is the protein-protein interaction between myomasp/LRRC39 and myosin/MYH7. MYH7 is connected to the M-band via its interaction with myomesin at the A-band/M-band transition zone. [47] [48] [49] Mutations in the MYH7 gene are commonly found in patients experiencing hypertrophic and dilated cardiomyopathy. 50, 51 Most of these mutations affect the globular head region of the myosin molecule. In contrast, MYH7 mutations associated with skeletal muscle myosin storage myopathy with and without cardiomyopathy have almost exclusively been identified in the MYH7 C-terminal rod domain. 52, 53 Myomasp/LRRC39 directly interacts with the C-terminal coiled-coil myosin heavy chain tail region of MYH7. In addition, loss of myomasp/LRRC39 affects integrity of this A-band/M-band transition zone in zebrafish skeletal muscle. Thus, myomasp might also be an attractive candidate gene for this disorder and/or involved in its pathophysiology. It would be of special interest to see whether patients carrying this myosin mutation reveal an altered M-band architecture or a differential localization of myomasp/LRRC39.
In conclusion, we identified a novel heart-and musclespecific M-band protein termed myomasp/LRRC39, which interacts with MYH7 and negatively regulates stretchsensitive genes. Downregulation of myomasp/LRRC39 alters the molecular M-band composition via modulation of SRFdependent gene expression, as well as myocardial performance in vitro and in vivo.
Although we cannot rule out that structural alterations caused by abrogation of myomasp/LRRC39 result in changes in signaling and function, we interpret our results to support a role for myomasp/LRRC39 as a previously unrecognized component of an M-band-associated signaling pathway that regulates cardiomyocyte gene expression in response to biomechanical stress. Further in vivo gain-and loss-of-function experiments, as well as the analyses of myomasp/LRRC39 in patient samples, will help to clarify whether this novel sarcomeric protein also participates in the pathogenesis of cardiomyopathy.
Novelty and Significance
What Is Known?
• The sarcomeric contractile filaments are precisely crosslinked at the Z-disk and M-band to provide static stability. The Z-disk and M-band are structural hubs with additional signaling functions, integrating biomechanical strain with intracellular signaling pathways.
• Regular M-band assembly is needed for proper packing of the thick filaments with appropriate distances to the thin filaments at the onset of contraction.
• M-band-associated proteins have also been implicated n intracellular signaling processes and mechanotransduction.
What New Information Does This Article Contribute?
• We identified a cardiac-enriched transcript encoding for a novel component of the sarcomeric M-band, which we termed myomasp.
• Biomechanical strain in vitro, as well as in hearts subjected to aortic banding in vivo, led to marked downregulation of myomasp expression.
• Knockdown of myomasp/LRRC39 expression in vitro results in the inhibition of serum response factor (SRF)-dependent signaling and downregulation of M-band proteins myomesin-1 and -2, whereas the expression of stress-responsive genes such as GDF-15 and brain natriuretic peptide (BNP) is induced. In vivo knockdown of myomasp/LRRC39 in zebrafish resulted in reduced contractility, cardiomyopathy, and perturbed ultrastructural M-band architecture.
The Z-disk and the M-band are increasingly recognized as sarcomeric hubs with structural and signaling functions, integrating information on stretch with pathways controlling muscle growth and protein turnover. In this study, we found a novel cardiac-enriched protein, termed myomasp. Immunolocalization identified myomasp as component of the sarcomeric M-band, and interaction studies confirmed the C terminus of myosin heavy chain (MYH)7 as an interaction partner. We found that myomasp mRNA expression was reduced in neonatal rat ventricular myocyte (NRVCM) subjected to static stretch or mice that underwent transverse aortic constriction. Myomasp knockdown in NRVCM led to an upregulation of the stretch-sensitive genes GDF-15 and BNP, whereas expression of MYH7 mRNA and the M-band proteins myomesin-1 and -2 was reduced. Knockdown of myomasp suppressed SRF-dependent gene expression, consistent with observations linking the M-band to SRF-mediated signaling. Downregulation of myomasp in engineered heart tissue constructs decreased force generation and reduced fractional shortening. In vivo, myomasp-null zebrafish reveal reduced contractile function performance and ultrastructural M-band alterations, with marked reduction of the A-band/ M-band transition zone. These observations support the concept that myomasp plays a critical role in maintaining M-band integrity, as well as regular contractile performance.
